FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $2.5B
1-Year Est. Return 52.94%
This Quarter Est. Return
1 Year Est. Return
+52.94%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.87B
AUM Growth
+$366M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
56
New
Increased
Reduced
Closed

Top Buys

1
+$22.3M
2
+$19.9M
3
+$16.2M
4
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$16.1M
5
DYN icon
Dyne Therapeutics
DYN
+$15.8M

Top Sells

1
+$42.4M
2
+$14.3M
3
+$8.71M
4
REPL icon
Replimune Group
REPL
+$6.62M
5
PRTA icon
Prothena Corp
PRTA
+$6.17M

Sector Composition

1 Healthcare 99.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$192M 10.25%
6,495,392
+25,000
2
$157M 8.39%
9,781,472
3
$136M 7.25%
12,131,705
4
$123M 6.56%
988,460
5
$110M 5.88%
2,725,949
6
$109M 5.83%
2,371,304
7
$92.3M 4.93%
10,109,279
8
$73.1M 3.91%
1,164,405
9
$59.9M 3.2%
3,014,349
10
$59.7M 3.19%
3,131,008
+145,251
11
$53M 2.83%
885,165
+271,122
12
$45.6M 2.44%
1,523,013
+120,000
13
$45.3M 2.42%
785,000
+130,000
14
$44.4M 2.37%
3,622,294
+383,435
15
$36.2M 1.94%
1,787,527
16
$29.2M 1.56%
2,667,203
+1,818,181
17
$28.6M 1.53%
997,455
18
$28.5M 1.52%
1,388,889
19
$28.3M 1.51%
8,764,232
+80,000
20
$27.3M 1.46%
34,425
21
$24.1M 1.29%
3,746,857
22
$23.1M 1.24%
2,401,704
+598,500
23
$22.9M 1.22%
730,917
+100,020
24
$22.3M 1.19%
+2,000,000
25
$20.5M 1.1%
746,479
1
2 3